First-in-human Phase 1b Study of the Dopamine β-Hydroxylase Inhibitor APL-1401 in Patients with Moderate-to-Severe ULCERATIVE COLITIS: Pharmacokinetics and Preliminary Results

nepicastat (APL-1401) - Asieris

X. Liu1; G. Reiss2; L. Lopez3; C. Zheng4; X. Zhang5; P. An6; Y. Zhang7; H. Yuan8; Y. Cao9; Q. Qin1; X. Yuan10,.

Dec 20, 2025